Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Tumors Cancer Clinical Trial
NCT02988960 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 163 Participants

This is a dose-escalation study designed to evaluate the safety, pharmacokinetics, and pharmacodynamics of ABBV-927, and to determine the maximum tolerated dose (MTD) or recommended Phase 2 dose (RPTD) for ABBV-927 when administered as monotherapy or as combination therapy with ABBV-181 in participants with advanced solid tumors.